Becton Dickinson (BDX) Capital Expenditures (2009 - 2026)
Becton Dickinson's (BDX) quarterly Capital Expenditures came in at $125.0 million in Q1 2026, up 9.65% year-on-year from $114.0 million in Q1 2025, and up 15.74% on a QoQ basis from $108.0 million in Q4 2025.
Becton Dickinson (BDX) Capital Expenditures (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Capital Expenditures data on file, last reported at $125.0 million in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 9.65% year-over-year to $125.0 million in Q1 2026; TTM through Mar 2026 was $774.0 million, a 11.53% increase from a year earlier, with the FY2025 full-year figure at $760.0 million, up 4.83% from the prior year.
- Capital Expenditures for Q1 2026 stood at $125.0 million, up from $108.0 million in the prior quarter.
- Over the last five years, Capital Expenditures for BDX reached as high as $352.0 million in Q3 2025 and fell as low as $105.0 million in Q4 2024.
- Historically, Capital Expenditures has averaged $198.9 million across 5 years, with a median of $189.0 million in 2025.
- Across the five-year window, Capital Expenditures tumbled 44.23% in 2023 and grew 18.92% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $208.0 million in 2022, then tumbled by 44.23% to $116.0 million in 2023, then decreased by 9.48% to $105.0 million in 2024, then rose by 2.86% to $108.0 million in 2025, then advanced by 15.74% to $125.0 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $125.0 million in Q1 2026, $108.0 million in Q4 2025, and $352.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 137.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.00 Mn |
| Mar 31, 2026 | 125.00 Mn |
| Dec 31, 2025 | 108.00 Mn |
| Dec 31, 2025 | 108.00 Mn |
| Sep 30, 2025 | 352.00 Mn |
| Sep 30, 2025 | 352.00 Mn |
| Jun 30, 2025 | 189.00 Mn |
| Jun 30, 2025 | 189.00 Mn |
| Mar 31, 2025 | 114.00 Mn |
| Mar 31, 2025 | 114.00 Mn |
| Dec 31, 2024 | 105.00 Mn |
| Dec 31, 2024 | 105.00 Mn |
| Sep 30, 2024 | 296.00 Mn |
| Sep 30, 2024 | 296.00 Mn |
| Jun 30, 2024 | 179.00 Mn |
| Jun 30, 2024 | 179.00 Mn |
| Mar 31, 2024 | 134.00 Mn |
| Mar 31, 2024 | 134.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Dec 31, 2023 | 116.00 Mn |